Trial Profile
Special Drug Use Survey of HERNICORE 1.25 units for intradiscal injection in Patients with Lumbar Disc Herniation
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 24 May 2020
Price :
$35
*
At a glance
- Drugs Condoliase (Primary)
- Indications Intervertebral disc displacement
- Focus Adverse reactions; Therapeutic Use
- Sponsors Seikagaku Corporation
- 05 Mar 2019 Status changed from not yet recruiting to recruiting.
- 08 Nov 2018 New trial record